These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 34974994)
1. Impact of COVID-19 lockdown on people living with diabetes: Experience from a low-middle income country in South Asia. Dissanayake H; Soysa P; Samarathunga T; De Silva L; Samaranayake N; Padmaperuma C; Katulanda P Prim Care Diabetes; 2022 Feb; 16(1):127-134. PubMed ID: 34974994 [TBL] [Abstract][Full Text] [Related]
2. Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South India. Sankar P; Ahmed WN; Mariam Koshy V; Jacob R; Sasidharan S Diabetes Metab Syndr; 2020; 14(6):1815-1819. PubMed ID: 32956926 [TBL] [Abstract][Full Text] [Related]
3. Impact of COVID-19 lockdown on glycaemic control and lifestyle changes in children and adolescents with type 1 and type 2 diabetes mellitus. Cheng HP; Wong JSL; Selveindran NM; Hong JYH Endocrine; 2021 Sep; 73(3):499-506. PubMed ID: 34244903 [TBL] [Abstract][Full Text] [Related]
4. Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study. D'Onofrio L; Pieralice S; Maddaloni E; Mignogna C; Sterpetti S; Coraggio L; Luordi C; Guarisco G; Leto G; Leonetti F; Manfrini S; Buzzetti R Diabetes Obes Metab; 2021 Jul; 23(7):1624-1630. PubMed ID: 33764666 [TBL] [Abstract][Full Text] [Related]
5. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England. Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723 [TBL] [Abstract][Full Text] [Related]
6. Impact of the COVID-19 Pandemic on the Health Status and Behaviors of Adults in Korea: National Cross-sectional Web-Based Self-report Survey. Kang E; Lee H; Sohn JH; Yun J; Lee JY; Hong YC JMIR Public Health Surveill; 2021 Nov; 7(11):e31635. PubMed ID: 34653017 [TBL] [Abstract][Full Text] [Related]
7. Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people. Karatas S; Yesim T; Beysel S Prim Care Diabetes; 2021 Jun; 15(3):424-427. PubMed ID: 33441263 [TBL] [Abstract][Full Text] [Related]
8. Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies. Silverii GA; Delli Poggi C; Dicembrini I; Monami M; Mannucci E Acta Diabetol; 2021 Dec; 58(12):1603-1611. PubMed ID: 34159476 [TBL] [Abstract][Full Text] [Related]
9. Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from Lockdown. Anjana RM; Pradeepa R; Deepa M; Jebarani S; Venkatesan U; Parvathi SJ; Balasubramanyam M; Radha V; Poongothai S; Sudha V; Shanthi Rani CS; Ranjani H; Amutha A; Manickam N; Unnikrishnan R; Mohan V Diabetes Technol Ther; 2020 Jul; 22(7):527-534. PubMed ID: 32522031 [No Abstract] [Full Text] [Related]
10. Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy. Falcetta P; Aragona M; Ciccarone A; Bertolotto A; Campi F; Coppelli A; Dardano A; Giannarelli R; Bianchi C; Del Prato S Diabetes Res Clin Pract; 2021 Apr; 174():108750. PubMed ID: 33722703 [TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain. Palanca A; Quinones-Torrelo C; Girbés J; Real JT; Ampudia-Blasco FJ Eur J Clin Invest; 2022 Jun; 52(6):e13771. PubMed ID: 35313009 [TBL] [Abstract][Full Text] [Related]
12. The COVID-19 lockdown does not necessarily worsen diabetes control, in spite of lower physical activity - a systematic review. Aldukhayel A Endokrynol Pol; 2022; 73(1):131-148. PubMed ID: 35119094 [TBL] [Abstract][Full Text] [Related]
13. The impact of COVID-19 lockdown on glycaemic control in young adults with type 1 diabetes mellitus. Lockhart M; Green D; Smith D Ir J Med Sci; 2023 Apr; 192(2):671-673. PubMed ID: 35701647 [TBL] [Abstract][Full Text] [Related]
14. Dietary Changes During COVID-19 Lockdown in Adults With Type 1 Diabetes on a Hybrid Artificial Pancreas. Vetrani C; Calabrese I; Di Rienzo S; Pagliuca M; Rivieccio A; De Angelis R; Riccardi G; Rivellese AA; Annuzzi G; Bozzetto L Front Public Health; 2021; 9():752161. PubMed ID: 34778186 [TBL] [Abstract][Full Text] [Related]
15. Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes. Potier L; Hansel B; Larger E; Gautier JF; Carreira D; Assemien R; Lantieri O; Riveline JP; Roussel R Diabetes Care; 2021 Mar; 44(3):839-843. PubMed ID: 33361146 [TBL] [Abstract][Full Text] [Related]
16. Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes. Caruso I; Di Molfetta S; Guarini F; Giordano F; Cignarelli A; Natalicchio A; Perrini S; Leonardini A; Giorgino F; Laviola L Diabetes Metab Res Rev; 2021 Sep; 37(6):e3404. PubMed ID: 32918324 [TBL] [Abstract][Full Text] [Related]
17. The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes. Hakonen E; Varimo T; Tuomaala AK; Miettinen PJ; Pulkkinen MA BMC Pediatr; 2022 Jan; 22(1):48. PubMed ID: 35045807 [TBL] [Abstract][Full Text] [Related]
18. Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom. Avari P; Unsworth R; Rilstone S; Uduku C; Logan KM; Hill NE; Godsland IF; Reddy M; Oliver N PLoS One; 2021; 16(7):e0254951. PubMed ID: 34283880 [TBL] [Abstract][Full Text] [Related]
19. Effect of Lockdown on Diabetes Care During the COVID-19 Pandemic: Result of a Telephone-Based Survey Among Patients Attending a Diabetic Clinic in Northern India. Verma M; Sharma P; Chaudhari A; Sharma M; Kalra S Cureus; 2021 Oct; 13(10):e18489. PubMed ID: 34754650 [TBL] [Abstract][Full Text] [Related]
20. Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia. Chandran M; Hao Y; Kwee AK; Cheen MHH; Chin YA; Ng VYT Osteoporos Int; 2022 Jan; 33(1):251-261. PubMed ID: 34417842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]